MGRX — MANGOCEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $315,227 | -38.9% | -$15.1M | — | -136.3% | 64.3% | -1909.1% | — | — | — | — |
Revenue YoY trend Net margin trend
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 19 SEC-registered investment managers reported holding MGRX (MANGOCEUTICALS INC) in their latest 13F filings, with a combined reported value of $713.10K across 1.67M shares. That is +23.9% by share count (+275.75K shares) versus the previous quarter, while reported value moved +39.6%. Ownership is concentrated: the five largest holders account for 81.3% of reported value and the top ten for 95.6%.
Compared with the prior quarter, 4 opened new positions, 3 added to existing stakes, 4 trimmed, 4 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of MANGOCEUTICALS INC (MGRX) include ARMISTICE CAPITAL, LLC, Vanguard Group, Geode Capital Management, ranked by reported 13F value among the 45 institutional holders on this page.
MGRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 19 | 1.67M | $713.10K | +23.9% |
| Q2 2026 | 19 | 1.36M | $515.00K | +20.4% |
| Q1 2026 | 18 | 826.48K | $297.62K | +30.1% |
| Q4 2025 | 18 | 2.54M | $1.88M | +112.8% |
| Q3 2025 | 11 | 374.56K | $820.06K | +28.5% |
| Q2 2025 | 10 | 292.25K | $444.22K | -0.2% |
| Q1 2025 | 8 | 75.32K | $146.87K | +26.3% |
| Q4 2024 | 9 | 91.34K | $220.94K | -93.4% |
Over the 8 quarters shown, institutional share counts increased 1726% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+112.8%).
Top Institutional Holders (Q3 2026) — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 689.27K | $295.08K | 0.00% | Add | |
| 214.63K | $91.88K | 0.00% | New | |
| 189.00K | $80.91K | 0.00% | Reduce | |
| 138.15K | $59.14K | 0.01% | Hold | |
| 123.04K | $52.66K | 0.00% | Hold | |
| 70.60K | $30.22K | 0.00% | Add | |
| 57.16K | $24.47K | 0.00% | Hold | |
| 38.44K | $16.46K | 0.00% | Hold | |
| 37.58K | $16.09K | 0.00% | Hold | |
| 34.50K | $14.77K | 0.00% | Hold | |
| 22.18K | $9.49K | 0.00% | Reduce | |
| 24.10K | $9.40K | 0.00% | New | |
| 12.31K | $5.27K | 0.00% | Reduce | |
| 10.00K | $4.28K | 0.00% | Hold | |
| 3.07K | $1.32K | 0.00% | Add | |
| 2.88K | $1.24K | 0.00% | Hold | |
| 763 | $327 | 0.00% | Reduce | |
| 121 | $53 | 0.00% | New | |
| 100 | $43 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 338.96K | $128.81K | 0.00% | New | |
| 186.26K | $70.78K | 0.00% | Add | |
| 156.24K | $59.37K | 0.00% | New | |
| 156.24K | $59.37K | 0.00% | Reduce | |
| 138.15K | $52.50K | 0.01% | Hold | |
| 123.04K | $46.76K | 0.00% | Hold | |
| 57.16K | $21.72K | 0.00% | Hold | |
| 38.44K | $14.61K | 0.00% | Hold | |
| 37.58K | $14.28K | 0.00% | Hold | |
| 34.50K | $13.11K | 0.00% | Hold | |
| 36.00K | $13.00K | 0.00% | New | |
| 26.86K | $10.21K | 0.00% | New | |
| 11.59K | $4.40K | 0.00% | Reduce | |
| 10.00K | $3.80K | 0.00% | Hold | |
| 2.88K | $1.10K | 0.00% | New | |
| 1.34K | $510 | 0.00% | Hold | |
| 1.00K | $380 | 0.00% | Hold | |
| 783 | $298 | 0.00% | Hold | |
| 5 | $2 | 0.00% | New |
Q1 2026 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 194.48K | $70.03K | 0.00% | Add | |
| 138.15K | $49.75K | 0.01% | Hold | |
| 123.04K | $44.30K | 0.00% | New | |
| 72.75K | $26.20K | 0.00% | Add | |
| 61.03K | $22.00K | 0.00% | Add | |
| 57.16K | $20.58K | 0.00% | New | |
| 38.44K | $13.84K | 0.00% | Hold | |
| 37.58K | $13.53K | 0.00% | Hold | |
| 34.50K | $12.42K | 0.00% | Hold | |
| 16.04K | $5.78K | 0.00% | New | |
| 13.14K | $4.73K | 0.00% | New | |
| 12.00K | $4.32K | 0.00% | Hold | |
| 11.76K | $4.23K | 0.00% | New | |
| 10.00K | $3.60K | 0.00% | Hold | |
| 3.29K | $1.18K | 0.00% | Add | |
| 1.34K | $484 | 0.00% | Add | |
| 1.00K | $360 | 0.00% | Hold | |
| 785 | $283 | 0.00% | Reduce |
Q4 2025 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.54M | $1.14M | 0.01% | New | |
| 489.53K | $362.25K | 0.00% | Add | |
| 138.15K | $102.23K | 0.01% | New | |
| 108.32K | $80.16K | 0.00% | Add | |
| 47.50K | $35.15K | 0.00% | New | |
| 46.17K | $34.16K | 0.00% | Add | |
| 38.44K | $28.45K | 0.00% | New | |
| 37.58K | $27.81K | 0.00% | Add | |
| 34.50K | $25.53K | 0.01% | Hold | |
| 33.46K | $25.00K | 0.00% | New | |
| 12.00K | $8.88K | 0.00% | Add | |
| 10.00K | $7.40K | 0.00% | New | |
| 2.88K | $2.13K | 0.00% | Hold | |
| 1.00K | $741 | 0.00% | New | |
| 1.00K | $740 | 0.00% | New | |
| 378 | $280 | 0.00% | New | |
| 107 | $79 | 0.00% | Reduce | |
| 1 | $1 | 0.00% | New |
Q3 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 192.00K | $420.49K | 0.00% | Add | |
| 87.97K | $192.66K | 0.00% | Add | |
| 34.50K | $75.56K | 0.02% | Hold | |
| 28.51K | $62.45K | 0.00% | New | |
| 18.96K | $41.52K | 0.00% | New | |
| 7.00K | $15.33K | 0.00% | New | |
| 2.88K | $6.09K | 0.00% | Hold | |
| 2.09K | $4.59K | 0.00% | Hold | |
| 451 | $1.00K | 0.00% | New | |
| 176 | $386 | 0.00% | Add | |
| 3 | $7 | 0.00% | Reduce |
Q2 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 182.61K | $277.57K | 0.00% | New | |
| 34.50K | $52.44K | 0.01% | Hold | |
| 31.00K | $47.12K | 0.00% | New | |
| 26.50K | $40.28K | 0.00% | Add | |
| 10.57K | $16.07K | 0.00% | New | |
| 2.88K | $4.38K | 0.00% | Hold | |
| 2.09K | $3.18K | 0.00% | Hold | |
| 1.85K | $2.81K | 0.00% | Add | |
| 163 | $247 | 0.00% | Add | |
| 79 | $120 | 0.00% | Reduce |
New Positions (Q3 2026)
- JANE STREET GROUP, LLC 214.63K sh · $91.88K
- StoneX Group Inc. 24.10K sh · $9.40K
- Robinhood Markets, Inc. 121 sh · $53
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 100 sh · $43
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 156.24K sh · $59.37K
- HRT FINANCIAL LP sold 36.00K sh · $13.00K
- Goldman Sachs Group sold 11.59K sh · $4.40K
- BARCLAYS PLC sold 5 sh · $2
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 689.27K | 156.24K | 194.48K | 108.32K | 87.97K | 26.50K | 19.57K | 12.00K | 131.33K | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 214.63K | — | 72.75K | 47.50K | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 189.00K | 338.96K | — | — | — | — | — | — | — | 133.19K | 114.40K | 22.31K | 47.18K | — | — |
| Ikarian Capital, LLC | 138.15K | 138.15K | 138.15K | 138.15K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 123.04K | 123.04K | 123.04K | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 70.60K | 1.00K | 1.00K | 1.00K | — | — | — | — | — | 10.36K | 10.36K | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 57.16K | 57.16K | 57.16K | — | — | — | — | — | — | — | — | — | — | — | — |
| BOOTHBAY FUND MANAGEMENT, LLC | 38.44K | 38.44K | 38.44K | 38.44K | — | — | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | 37.58K | 37.58K | 37.58K | 37.58K | 18.96K | — | — | — | — | — | — | — | — | — | — |
| Ackerman Capital Advisors, LLC | 34.50K | 34.50K | 34.50K | 34.50K | 34.50K | 34.50K | 34.50K | 34.50K | 873.36K | — | — | — | — | — | — |
| XTX Topco Ltd | 22.18K | 186.26K | 13.14K | — | 28.51K | — | — | — | 28.83K | — | 24.35K | — | — | — | — |
| StoneX Group Inc. | 24.10K | — | 16.04K | — | — | — | — | — | — | — | — | — | — | — | — |
| ACT Advisors, LLC. | 12.31K | 26.86K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Csenge Advisory Group | 10.00K | 10.00K | 10.00K | 10.00K | — | — | — | — | — | — | — | — | — | — | — |
| Fortitude Family Office, LLC | 3.07K | 1.34K | 1.34K | 378 | — | — | — | — | — | — | — | — | — | — | — |
| AMERIFLEX GROUP, INC. | 2.88K | 2.88K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 763 | 783 | 785 | 1.00K | — | 1.85K | 1.64K | 2.63K | — | — | — | — | — | — | — |
| Robinhood Markets, Inc. | 121 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 100 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | 1.54M | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold MGRX?
As of 2026-Q3, 19 institutional funds reported holding MGRX (MANGOCEUTICALS INC) in SEC 13F filings, with a combined reported value of $713.10K.
How many shares of MGRX do institutions own?
13F filers reported 1.67M shares of MGRX, worth $713.10K in aggregate at the end of 2026-Q3.
Is institutional ownership of MGRX rising or falling?
Share counts moved +23.9% versus the prior quarter — accumulation.
Who are the top institutional holders of MGRX?
The largest 13F holders are ARMISTICE CAPITAL, LLC, Vanguard Group, Geode Capital Management, JANE STREET GROUP, LLC, Citadel Advisors; the top 25 are ranked at the top of this page.
Who are the major shareholders of MANGOCEUTICALS INC?
The major shareholders of MANGOCEUTICALS INC (MGRX) by reported 13F value are ARMISTICE CAPITAL, LLC, Vanguard Group, Geode Capital Management, JANE STREET GROUP, LLC, Citadel Advisors, among 45 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.